Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 7 studies | 28% ± 8% | |
adipocyte | 3 studies | 21% ± 3% | |
fibroblast | 3 studies | 20% ± 3% | |
glutamatergic neuron | 3 studies | 22% ± 4% | |
endothelial cell | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney | 3 studies | 16% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 3460.27 | 89 / 89 | 91% | 103.47 | 824 / 901 |
thymus | 100% | 801.61 | 653 / 653 | 85% | 27.26 | 514 / 605 |
brain | 94% | 241.56 | 2477 / 2642 | 77% | 17.53 | 544 / 705 |
breast | 95% | 492.08 | 438 / 459 | 63% | 11.37 | 707 / 1118 |
lung | 100% | 808.72 | 578 / 578 | 55% | 19.61 | 634 / 1155 |
skin | 59% | 254.76 | 1070 / 1809 | 92% | 33.36 | 433 / 472 |
intestine | 94% | 425.96 | 908 / 966 | 45% | 6.22 | 239 / 527 |
bladder | 100% | 463.14 | 21 / 21 | 26% | 5.31 | 133 / 504 |
ovary | 100% | 1499.79 | 180 / 180 | 26% | 3.07 | 113 / 430 |
uterus | 98% | 333.84 | 166 / 170 | 22% | 3.63 | 99 / 459 |
esophagus | 89% | 423.82 | 1280 / 1445 | 31% | 4.07 | 56 / 183 |
stomach | 70% | 288.71 | 252 / 359 | 44% | 5.72 | 125 / 286 |
prostate | 100% | 488.76 | 244 / 245 | 11% | 0.93 | 56 / 502 |
blood vessel | 100% | 1006.26 | 1334 / 1335 | 0% | 0 | 0 / 0 |
spleen | 99% | 294.95 | 238 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 93% | 322.19 | 239 / 258 | 5% | 0.68 | 12 / 230 |
pancreas | 17% | 27.70 | 57 / 328 | 78% | 19.78 | 138 / 178 |
eye | 0% | 0 | 0 / 0 | 94% | 26.39 | 75 / 80 |
adipose | 93% | 393.88 | 1115 / 1204 | 0% | 0 | 0 / 0 |
liver | 71% | 186.51 | 160 / 226 | 16% | 2.84 | 63 / 406 |
heart | 86% | 290.77 | 740 / 861 | 0% | 0 | 0 / 0 |
muscle | 37% | 62.97 | 299 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 2.60 | 6 / 29 |
peripheral blood | 16% | 23.20 | 151 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015718 | Biological process | monocarboxylic acid transport |
GO_0055085 | Biological process | transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0015293 | Molecular function | symporter activity |
GO_0008028 | Molecular function | monocarboxylic acid transmembrane transporter activity |
Gene name | SLC16A4 |
Protein name | Monocarboxylate transporter 5 Monocarboxylate transporter 5 (MCT 5) (Monocarboxylate transporter 4) (MCT 4) (Solute carrier family 16 member 4) Solute carrier family 16 member 4 |
Synonyms | MCT4 MCT5 |
Description | FUNCTION: Proton-linked monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate (By similarity). . |
Accessions | ENST00000472422.6 [O15374-5] ENST00000467986.2 ENST00000369779.9 [O15374-1] ENST00000541986.5 [O15374-2] ENST00000461647.6 H0YEG4 A0A1S5UZI1 E9PKZ1 E9PRV1 O15374 ENST00000528649.5 ENST00000492412.2 ENST00000369781.8 [O15374-3] ENST00000437429.6 [O15374-4] |